“…Recipients receiving grafts recovered using TA-NRP were younger (44 versus 57 [47-65] y, P < 0.001), were less likely to have diabetes (24.2% versus 41.8%, P < 0.001), spent more years on dialysis (4.5 [2.5-6.8] versus 3.9 [2.0-5.9] y, P = 0.003), and were more likely to be blood group O (60.8% versus 45.9%, P < 0.001) compared with recipients of direct recovery grafts. TA-NRP donors had similar time between withdrawal of life support and asystole (19 [15-27] versus 19 [14][15][16][17][18][19][20][21][22][23][24][25][26] min, P = 0.05) and, by definition, longer time between declaration of death and aortic cross-clamp (71 [59-103] versus 7 [4-9] min, P < 0.001). Donors for which TA-NRP was used were more likely to be shared nationally (27.5% versus 24.6%, P = 0.02).…”